{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:54:10Z","timestamp":1762520050238},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T00:00:00Z","timestamp":1258588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T00:00:00Z","timestamp":1258588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/leu.2009.227","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T16:29:12Z","timestamp":1258648152000},"page":"187-196","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Heat stress triggers apoptosis by impairing NF-\u03baB survival signaling in malignant B cells"],"prefix":"10.1038","volume":"24","author":[{"given":"G","family":"Belardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Piva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M G","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,19]]},"reference":[{"key":"BFleu2009227_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma I . NF-kappaB regulation in the immune system. Nat Rev Immunol 2002; 2: 725\u2013734.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2009227_CR2","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/emboj\/cdg267","volume":"22","author":"MG Santoro","year":"2003","unstructured":"Santoro MG, Rossi A, Amici C . NF-kappaB and virus infection: who controls whom. EMBO J 2003; 22: 2552\u20132560.","journal-title":"EMBO J"},{"key":"BFleu2009227_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni0302-221","volume":"3","author":"M Karin","year":"2002","unstructured":"Karin M, Lin A . NF-kappaB at the crossroads of life and death. Nat Immunol 2002; 3: 221\u2013227.","journal-title":"Nat Immunol"},{"key":"BFleu2009227_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","volume":"25","author":"G Bonizzi","year":"2004","unstructured":"Bonizzi G, Karin M . The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25: 280\u2013288.","journal-title":"Trends Immunol"},{"key":"BFleu2009227_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M . Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441: 431\u2013436.","journal-title":"Nature"},{"key":"BFleu2009227_CR6","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1038\/sj.onc.1203221","volume":"18","author":"B Rayet","year":"1999","unstructured":"Rayet B, Gelinas C . Aberrant rel\/nfkb genes and activity in human cancer. Oncogene 1999; 18: 6938\u20136947.","journal-title":"Oncogene"},{"key":"BFleu2009227_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/JCI11891","volume":"107","author":"AS Baldwin Jr","year":"2001","unstructured":"Baldwin Jr AS . The transcription factor NF-kappaB and human disease. J Clin Invest 2001; 107: 3\u20136.","journal-title":"J Clin Invest"},{"key":"BFleu2009227_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1046\/j.1365-2141.2001.03102.x","volume":"115","author":"H Ni","year":"2001","unstructured":"Ni H, Ergin M, Huang Q, Qin JZ, Amin HM, Martinez RL et al. Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis. Br J Haematol 2001; 115: 279\u2013286.","journal-title":"Br J Haematol"},{"key":"BFleu2009227_CR9","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1172\/JCI119849","volume":"100","author":"RC Bargou","year":"1997","unstructured":"Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997; 100: 2961\u20132969.","journal-title":"J Clin Invest"},{"key":"BFleu2009227_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1074-7613(01)00258-8","volume":"16","author":"LV Pham","year":"2002","unstructured":"Pham LV, Tamayo A, Yoshimura LC, Lo P, Terry N, Reid PS et al. A CD40 signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas. Immunity 2002; 16: 37\u201350.","journal-title":"Immunity"},{"key":"BFleu2009227_CR11","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","volume":"194","author":"RE Davis","year":"2001","unstructured":"Davis RE, Brown KD, Siebenlist U, Staudt LM . Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2001; 194: 1861\u20131874.","journal-title":"J Exp Med"},{"key":"BFleu2009227_CR12","first-page":"4342","volume":"58","author":"RZ Orlowski","year":"1998","unstructured":"Orlowski RZ, Eswara JR, Lafond-Walker A, Grever MR, Orlowski M, Dang CV . Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor. Cancer Res 1998; 58: 4342\u20134348.","journal-title":"Cancer Res"},{"key":"BFleu2009227_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1073\/pnas.94.2.746","volume":"94","author":"A Rossi","year":"1997","unstructured":"Rossi A, Elia G, Santoro MG . Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. Proc Natl Acad Sci USA 1997; 94: 746\u2013750.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009227_CR14","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1101\/gad.12.24.3788","volume":"12","author":"RI Morimoto","year":"1998","unstructured":"Morimoto RI . Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 1998; 12: 3788\u20133796.","journal-title":"Genes Dev"},{"key":"BFleu2009227_CR15","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1093\/jnci\/92.19.1564","volume":"92","author":"C Jolly","year":"2000","unstructured":"Jolly C, Morimoto RI . Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000; 92: 1564\u20131572.","journal-title":"J Natl Cancer Inst"},{"key":"BFleu2009227_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nbt0998-833","volume":"16","author":"RI Morimoto","year":"1998","unstructured":"Morimoto RI, Santoro MG . Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat Biotechnol 1998; 16: 833\u2013838.","journal-title":"Nat Biotechnol"},{"key":"BFleu2009227_CR17","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1128\/MCB.17.4.2107","volume":"17","author":"MP Kline","year":"1997","unstructured":"Kline MP, Morimoto RI . Repression of the heat shock factor 1 transcriptional activation domain is modulated by constitutive phosphorylation. Mol Cell Biol 1997; 17: 2107\u20132115.","journal-title":"Mol Cell Biol"},{"key":"BFleu2009227_CR18","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1096\/fj00-0294rev","volume":"15","author":"L Pirkkala","year":"2001","unstructured":"Pirkkala L, Nykanen P, Sistonen L . Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J 2001; 15: 1118\u20131131.","journal-title":"FASEB J"},{"key":"BFleu2009227_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/978-0-387-39975-1_8","volume":"594","author":"J Anckar","year":"2007","unstructured":"Anckar J, Sistonen L . Heat shock factor 1 as a coordinator of stress and developmental pathways. Adv Exp Med Biol 2007; 594: 78\u201388.","journal-title":"Adv Exp Med Biol"},{"key":"BFleu2009227_CR20","doi-asserted-by":"publisher","first-page":"9041","DOI":"10.1038\/sj.onc.1207114","volume":"22","author":"S Takayama","year":"2003","unstructured":"Takayama S, Reed JC, Homma S . Heat-shock proteins as regulators of apoptosis. Oncogene 2003; 22: 9041\u20139047.","journal-title":"Oncogene"},{"key":"BFleu2009227_CR21","doi-asserted-by":"publisher","first-page":"16446","DOI":"10.1074\/jbc.273.26.16446","volume":"273","author":"A Rossi","year":"1998","unstructured":"Rossi A, Elia G, Santoro MG . Activation of the heat shock factor 1 by serine protease inhibitors. An effect associated with nuclear factor-kappaB inhibition. J Biol Chem 1998; 273: 16446\u201316452.","journal-title":"J Biol Chem"},{"key":"BFleu2009227_CR22","doi-asserted-by":"publisher","first-page":"28759","DOI":"10.1074\/jbc.M103408200","volume":"276","author":"C Amici","year":"2001","unstructured":"Amici C, Belardo G, Rossi A, Santoro MG . Activation of I kappa B kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy. J Biol Chem 2001; 276: 28759\u201328766.","journal-title":"J Biol Chem"},{"key":"BFleu2009227_CR23","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1182\/blood-2007-07-100651","volume":"111","author":"R Piva","year":"2008","unstructured":"Piva R, Ruggeri B, Williams M, Costa G, Tamagno I, Ferrero D et al. CEP-18770: a novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib. Blood 2008; 111: 2765\u20132775.","journal-title":"Blood"},{"key":"BFleu2009227_CR24","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1182\/blood-2004-04-1360","volume":"105","author":"R Piva","year":"2005","unstructured":"Piva R, Gianferretti P, Ciucci A, Taulli R, Belardo G, Santoro MG . 15-deoxy-D12,14-prostaglandin J2 induces apoptosis in human malignant B-cells: an effect associated with inhibition of NF-\u03baB activity and down-regulation of anti-apoptotic proteins. Blood 2005; 105: 1750\u20131758.","journal-title":"Blood"},{"key":"BFleu2009227_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/47520","volume":"403","author":"A Rossi","year":"2000","unstructured":"Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 2000; 403: 103\u2013108.","journal-title":"Nature"},{"key":"BFleu2009227_CR26","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1128\/MCB.8.11.4736","volume":"8","author":"DD Mosser","year":"1988","unstructured":"Mosser DD, Theodorakis NG, Morimoto RI . Coordinate changes in heat shock element-binding activity and HSP70 gene transcription rates in human cells. Mol Cell Biol 1988; 8: 4736\u20134744.","journal-title":"Mol Cell Biol"},{"key":"BFleu2009227_CR27","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1124\/mol.106.025759","volume":"70","author":"A Ciucci","year":"2006","unstructured":"Ciucci A, Gianferretti P, Piva R, Guyot T, Snape TJ, Roberts SM et al. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase\/nuclear factor-kappaB pathway. Mol Pharmacol 2006; 70: 1812\u20131821.","journal-title":"Mol Pharmacol"},{"key":"BFleu2009227_CR28","doi-asserted-by":"publisher","first-page":"32338","DOI":"10.1074\/jbc.M004148200","volume":"275","author":"K Kanda","year":"2000","unstructured":"Kanda K, Hu HM, Zhang L, Grandchamps J, Boxer LM . NF-kappaB activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer. J Biol Chem 2000; 275: 32338\u201332346.","journal-title":"J Biol Chem"},{"key":"BFleu2009227_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev.cb.11.110195.002301","volume":"11","author":"C Wu","year":"1995","unstructured":"Wu C . Heat shock transcription factors: structure and regulation. Annu Rev Cell Dev Biol 1995; 11: 441\u2013469.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFleu2009227_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","volume":"43","author":"B Hildebrandt","year":"2002","unstructured":"Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 33\u201356.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFleu2009227_CR31","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006; 354: 2431\u20132442.","journal-title":"N Engl J Med"},{"key":"BFleu2009227_CR32","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419\u20132430.","journal-title":"N Engl J Med"},{"key":"BFleu2009227_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature04687","volume":"441","author":"VN Ngo","year":"2006","unstructured":"Ngo VN, Davis RE, Lamy L, Yu X, Zhao H, Lenz G et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 2006; 441: 106\u2013110.","journal-title":"Nature"},{"key":"BFleu2009227_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0006-2952(99)00299-3","volume":"59","author":"MG Santoro","year":"2000","unstructured":"Santoro MG . Heat shock factors and the control of the stress response. Biochem Pharmacol 2000; 59: 55\u201363.","journal-title":"Biochem Pharmacol"},{"key":"BFleu2009227_CR35","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1101\/gad.1188204","volume":"18","author":"R Ran","year":"2004","unstructured":"Ran R, Lu A, Zhang L, Tang Y, Zhu H, Xu H et al. Hsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling. Genes Dev 2004; 18: 1466\u20131481.","journal-title":"Genes Dev"},{"key":"BFleu2009227_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/sj.cdd.4402240","volume":"1","author":"C Frelin","year":"2008","unstructured":"Frelin C, Imbert V, Bottero V, Gonthier N, Samraj AK, Schulze-Osthoff K et al. Inhibition of the NF-kappaB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-kappaB essential modulator NEMO. Cell Death Differ 2008; 1: 152\u2013160.","journal-title":"Cell Death Differ"},{"key":"BFleu2009227_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrm1621","volume":"6","author":"DL Vaux","year":"2005","unstructured":"Vaux DL, Silke J . IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol 2005; 6: 287\u2013297.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFleu2009227_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00109-005-0003-7","volume":"84","author":"H D\u00fcrkop","year":"2006","unstructured":"D\u00fcrkop H, Hirsh B, Hahn C, Stein H . cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3. J Mol Med 2006; 84: 132\u2013141.","journal-title":"J Mol Med"},{"key":"BFleu2009227_CR39","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","volume":"131","author":"E Varfolomeev","year":"2007","unstructured":"Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 2007; 131: 669\u2013681.","journal-title":"Cell"},{"key":"BFleu2009227_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1084\/jem.20021279","volume":"198","author":"H Kashkar","year":"2003","unstructured":"Kashkar H, Haefs C, Shin H, Hamilton-Dutoit SJ, Salvesen GS, Kronke M et al. XIAP-mediated caspase inhibition in Hodgkin's lymphoma\u2013derived B cells. J Exp Med 2003; 198: 341\u2013347.","journal-title":"J Exp Med"},{"key":"BFleu2009227_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF02786486","volume":"19","author":"S Ghosh","year":"1999","unstructured":"Ghosh S . Regulation of inducible gene expression by the transcription factor NF-kappaB. Immunol Res 1999; 19: 183\u2013189.","journal-title":"Immunol Res"},{"key":"BFleu2009227_CR42","first-page":"3071","volume":"61","author":"T Hideshima","year":"2001","unstructured":"Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 2001; 61: 3071\u20133076.","journal-title":"Cancer Res"},{"key":"BFleu2009227_CR43","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1172\/JCI26471","volume":"115","author":"HM Beere","year":"2005","unstructured":"Beere HM . Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 2005; 115: 2633\u20132639.","journal-title":"J Clin Invest"},{"key":"BFleu2009227_CR44","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1038\/sj.onc.1207529","volume":"23","author":"DD Mosser","year":"2004","unstructured":"Mosser DD, Morimoto RI . Molecular chaperones and the stress of oncogenesis. Oncogene 2004; 23: 2907\u20132918.","journal-title":"Oncogene"},{"key":"BFleu2009227_CR45","doi-asserted-by":"publisher","first-page":"9616","DOI":"10.1074\/jbc.M512044200","volume":"281","author":"SD Westerheide","year":"2006","unstructured":"Westerheide SD, Kawahara TL, Orton K, Morimoto RI . Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem 2006; 281: 9616\u20139622.","journal-title":"J Biol Chem"},{"key":"BFleu2009227_CR46","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-05-3692","volume":"66","author":"N Zaarur","year":"2006","unstructured":"Zaarur N, Gabai V, Porco JA, Calderwood S, Sherman MY . Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Cancer Res 2006; 66: 1783\u20131791.","journal-title":"Cancer Res"},{"key":"BFleu2009227_CR47","doi-asserted-by":"publisher","first-page":"7678","DOI":"10.1158\/0008-5472.CAN-05-4282","volume":"66","author":"A Rossi","year":"2006","unstructured":"Rossi A, Ciafr\u00e8 S, Balsamo M, Pierimarchi P, Santoro MG . Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer. Cancer Res 2006; 66: 7678\u20137685.","journal-title":"Cancer Res"},{"key":"BFleu2009227_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1470-2045(02)00818-5","volume":"3","author":"P Wust","year":"2002","unstructured":"Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3: 487\u2013497.","journal-title":"Lancet Oncol"},{"key":"BFleu2009227_CR49","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1067\/msy.2002.119308","volume":"131","author":"I Takahashi","year":"2002","unstructured":"Takahashi I, Emi Y, Hasuda S, Kakeji Y, Maehara Y, Sugimachi K . Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors. Surgery 2002; 131: S48\u2013S54.","journal-title":"Surgery"},{"key":"BFleu2009227_CR50","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1182\/blood.V99.11.4079","volume":"99","author":"N Mitsiades","year":"2002","unstructured":"Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T et al. Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. Blood 2002; 99: 4079\u20134086.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2009227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009227","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:14:44Z","timestamp":1648728884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2009227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,19]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFleu2009227"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.227","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,19]]},"assertion":[{"value":"13 November 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}